| Knowledge4COVID-19

Property	Value
is ?:annotates of	<https://research.tib.eu/covid-19/entity/34699618_HAS_TOPIC_C0001675> <https://research.tib.eu/covid-19/entity/34699618_HAS_TOPIC_C0003451> <https://research.tib.eu/covid-19/entity/34699618_HAS_TOPIC_C0020155> <https://research.tib.eu/covid-19/entity/34699618_HAS_TOPIC_C0026062> <https://research.tib.eu/covid-19/entity/34699618_HAS_TOPIC_C0028138> <https://research.tib.eu/covid-19/entity/34699618_HAS_TOPIC_C0039859> <https://research.tib.eu/covid-19/entity/34699618_HAS_TOPIC_C0068788> <https://research.tib.eu/covid-19/entity/34699618_HAS_TOPIC_C0086287> <https://research.tib.eu/covid-19/entity/34699618_HAS_TOPIC_C0086418> <https://research.tib.eu/covid-19/entity/34699618_HAS_TOPIC_C0086582> <https://research.tib.eu/covid-19/entity/34699618_HAS_TOPIC_C0144444> <https://research.tib.eu/covid-19/entity/34699618_HAS_TOPIC_C0205847> <https://research.tib.eu/covid-19/entity/34699618_HAS_TOPIC_C0238598> <https://research.tib.eu/covid-19/entity/34699618_HAS_TOPIC_C1170029> <https://research.tib.eu/covid-19/entity/34699618_HAS_TOPIC_C1436431> <https://research.tib.eu/covid-19/entity/34699618_HAS_TOPIC_C1436432> <https://research.tib.eu/covid-19/entity/34699618_HAS_TOPIC_C1436433> <https://research.tib.eu/covid-19/entity/34699618_HAS_TOPIC_C1436434> <https://research.tib.eu/covid-19/entity/34699618_HAS_TOPIC_C1436435> <https://research.tib.eu/covid-19/entity/34699618_HAS_TOPIC_C1708335> <https://research.tib.eu/covid-19/entity/34699618_HAS_TOPIC_C1723765> <https://research.tib.eu/covid-19/entity/34699618_HAS_TOPIC_C2936405> <https://research.tib.eu/covid-19/entity/34699618_HAS_TOPIC_C3661466> <https://research.tib.eu/covid-19/entity/34699618_HAS_TOPIC_C3661486> <https://research.tib.eu/covid-19/entity/34699618_HAS_TOPIC_C5203670> <https://research.tib.eu/covid-19/entity/34699618_HAS_TOPIC_C5392141>
?:authorAffiliation	[\'University of Liverpool, Liverpool, UK.\', \'Liverpool University Hospitals NHS Foundation Trust, Liverpool, UK.\', \'Southampton Clinical Trials Unit, University of Southampton, Southampton, UK.\', \'Liverpool School of Tropical Medicine, Liverpool, UK.\', \'MRC Biostatistics Unit, University of Cambridge, Cambridge, UK.\']
?:citedBy	-1
?:creator	<https://research.tib.eu/covid-19/entity/Amara_Alieu> <https://research.tib.eu/covid-19/entity/Byrne_Kelly> <https://research.tib.eu/covid-19/entity/Crook_Rebecca> <https://research.tib.eu/covid-19/entity/Dilly-Penchala_Sujan> <https://research.tib.eu/covid-19/entity/Eberhart_Izabela> <https://research.tib.eu/covid-19/entity/Else_Laura> <https://research.tib.eu/covid-19/entity/Ewings_Sean> <https://research.tib.eu/covid-19/entity/Fines_Keira> <https://research.tib.eu/covid-19/entity/Fisher_Michael> <https://research.tib.eu/covid-19/entity/FitzGerald_Richard> <https://research.tib.eu/covid-19/entity/Fletcher_Thomas_E> <https://research.tib.eu/covid-19/entity/Griffiths_Gareth> <https://research.tib.eu/covid-19/entity/Hale_Colin> <https://research.tib.eu/covid-19/entity/Hatchard_Parys> <https://research.tib.eu/covid-19/entity/Jacobs_Michael> <https://research.tib.eu/covid-19/entity/Jaki_Thomas> <https://research.tib.eu/covid-19/entity/Johnson_Lucy> <https://research.tib.eu/covid-19/entity/Khoo_Saye> <https://research.tib.eu/covid-19/entity/Lalloo_David_G> <https://research.tib.eu/covid-19/entity/Lawrence_Megan> <https://research.tib.eu/covid-19/entity/Lyon_Rebecca> <https://research.tib.eu/covid-19/entity/Martin_Karen> <https://research.tib.eu/covid-19/entity/Mozgunov_Pavel> <https://research.tib.eu/covid-19/entity/Okenyi_Emmanuel> <https://research.tib.eu/covid-19/entity/Owen_Andrew> <https://research.tib.eu/covid-19/entity/Pertinez_Henry> <https://research.tib.eu/covid-19/entity/Rajoli_Rajith_K_R> <https://research.tib.eu/covid-19/entity/Reynolds_Helen> <https://research.tib.eu/covid-19/entity/Rowland_Timothy> <https://research.tib.eu/covid-19/entity/Saunders_Geoffrey> <https://research.tib.eu/covid-19/entity/Walker_Lauren_E> <https://research.tib.eu/covid-19/entity/Waugh_Robert> <https://research.tib.eu/covid-19/entity/Woods_Christie>
?:doi	10.1002/cpt.2463
?:doi	<https://research.tib.eu/covid-19/entity/10.1002/cpt.2463>
?:hasPublicationType	<https://research.tib.eu/covid-19/entity/Clinical_Trial%2C_Phase_I> <https://research.tib.eu/covid-19/entity/Journal_Article> <https://research.tib.eu/covid-19/entity/Research_Support%2C_N.I.H.%2C_Extramural> <https://research.tib.eu/covid-19/entity/Research_Support%2C_Non-U.S._Gov%27t>
?:journal	Clinical pharmacology and therapeutics
is ?:pmid of	<https://research.tib.eu/covid-19/entity/34699618>
?:pmid	<https://research.tib.eu/covid-19/entity/34699618>
?:pmid	34699618
?:publication_isRelatedTo_Disease	<https://research.tib.eu/covid-19/entity/Covid-19>
?:rankingScore_SJR	1.699
?:rankingScore_hIndex	169
is ?:relation_isRelatedTo_publication of	<https://research.tib.eu/covid-19/entity/C0068788_ADMINISTERED_TO_C0679646>
?:title	An Open Label, Adaptive, Phase 1 Trial of High-Dose Oral Nitazoxanide in Healthy Volunteers: An Antiviral Candidate for SARS-CoV-2.
?:type	<https://research.tib.eu/covid-19/vocab/Publication> <https://research.tib.eu/covid-19/vocab/Publication_Author>
?:year	2022

Metadata

Anon_0

<http://www.w3.org/1999/02/22-rdf-syntax-ns#type>

<http://purl.org/net/provenance/ns#DataItem>

<http://www.w3.org/1999/02/22-rdf-syntax-ns#type>

<http://www.w3.org/2004/03/trix/rdfg-1/Graph>

<http://xmlns.com/foaf/0.1/primaryTopic>

<https://research.tib.eu/covid-19/entity/34699618>

<http://xmlns.com/foaf/0.1/topic>

Anon_0

<http://www.ontologydesignpatterns.org/cp/owl/informationrealization.owl#realizes>

<https://research.tib.eu/covid-19/data/entity/34699618>

<http://purl.org/net/provenance/ns#createdBy>

Anon_1 (more)

expand all